GlaxoSmithKline Investments vs Accounts Payable Analysis

GSK Stock  USD 42.87  0.12  0.28%   
GlaxoSmithKline PLC financial indicator trend analysis is much more than just examining GlaxoSmithKline PLC ADR latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether GlaxoSmithKline PLC ADR is a good investment. Please check the relationship between GlaxoSmithKline PLC Investments and its Accounts Payable accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Investments vs Accounts Payable

Investments vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of GlaxoSmithKline PLC ADR Investments account and Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between GlaxoSmithKline PLC's Investments and Accounts Payable is -0.28. Overlapping area represents the amount of variation of Investments that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of GlaxoSmithKline PLC ADR, assuming nothing else is changed. The correlation between historical values of GlaxoSmithKline PLC's Investments and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Investments of GlaxoSmithKline PLC ADR are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Investments i.e., GlaxoSmithKline PLC's Investments and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.28
Relationship DirectionNegative 
Relationship StrengthInsignificant

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Accounts Payable

An accounting item on the balance sheet that represents GlaxoSmithKline PLC obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of GlaxoSmithKline PLC ADR are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from GlaxoSmithKline PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into GlaxoSmithKline PLC ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
At this time, GlaxoSmithKline PLC's Selling General Administrative is quite stable compared to the past year. Discontinued Operations is expected to rise to about 12.7 B this year, although the value of Tax Provision will most likely fall to about 669.3 M.
 2021 2022 2023 2024 (projected)
Interest Expense784M879M775M502.2M
Depreciation And Amortization2.6B2.4B2.3B1.2B

GlaxoSmithKline PLC fundamental ratios Correlations

0.92-0.320.890.50.890.90.770.610.990.370.590.220.16-0.070.950.950.770.970.320.910.710.70.120.940.12
0.92-0.310.830.410.880.980.710.650.90.340.560.020.08-0.150.910.90.810.910.230.870.870.730.030.820.01
-0.32-0.31-0.330.29-0.11-0.36-0.590.0-0.38-0.260.150.240.740.31-0.36-0.21-0.3-0.360.61-0.06-0.380.220.26-0.420.17
0.890.83-0.330.30.890.830.850.450.870.490.520.160.20.050.830.940.740.940.360.870.720.71-0.070.77-0.07
0.50.410.290.30.270.430.10.190.490.20.420.770.560.390.290.350.040.310.560.480.250.330.880.51-0.1
0.890.88-0.110.890.270.830.730.740.840.330.66-0.020.27-0.120.910.970.880.940.430.930.710.92-0.20.730.15
0.90.98-0.360.830.430.830.70.50.890.370.460.080.09-0.090.870.870.740.890.240.820.90.650.080.82-0.08
0.770.71-0.590.850.10.730.70.450.770.550.40.01-0.14-0.10.740.770.780.820.030.670.590.53-0.230.740.0
0.610.650.00.450.190.740.50.450.560.10.73-0.24-0.01-0.370.680.640.740.610.080.720.370.77-0.180.480.35
0.990.9-0.380.870.490.840.890.770.560.310.50.220.12-0.120.940.920.730.950.280.850.70.630.130.970.11
0.370.34-0.260.490.20.330.370.550.10.310.610.320.010.660.330.380.420.410.060.510.330.320.040.22-0.03
0.590.560.150.520.420.660.460.40.730.50.610.210.250.350.570.630.60.580.30.830.320.750.090.350.24
0.220.020.240.160.77-0.020.080.01-0.240.220.320.210.590.680.030.11-0.190.080.570.2-0.120.010.770.25-0.16
0.160.080.740.20.560.270.09-0.14-0.010.120.010.250.590.490.070.23-0.040.130.980.30.050.440.380.09-0.01
-0.07-0.150.310.050.39-0.12-0.09-0.1-0.37-0.120.660.350.680.49-0.18-0.05-0.22-0.090.420.13-0.090.00.42-0.18-0.14
0.950.91-0.360.830.290.910.870.740.680.940.330.570.030.07-0.180.940.870.970.250.870.710.71-0.120.880.27
0.950.9-0.210.940.350.970.870.770.640.920.380.630.110.23-0.050.940.840.980.40.940.70.82-0.080.820.13
0.770.81-0.30.740.040.880.740.780.740.730.420.6-0.19-0.04-0.220.870.840.850.130.80.590.78-0.40.640.29
0.970.91-0.360.940.310.940.890.820.610.950.410.580.080.13-0.090.970.980.850.310.910.750.74-0.110.880.14
0.320.230.610.360.560.430.240.030.080.280.060.30.570.980.420.250.40.130.310.430.180.540.30.260.02
0.910.87-0.060.870.480.930.820.670.720.850.510.830.20.30.130.870.940.80.910.430.650.880.060.720.14
0.710.87-0.380.720.250.710.90.590.370.70.330.32-0.120.05-0.090.710.70.590.750.180.650.55-0.030.65-0.25
0.70.730.220.710.330.920.650.530.770.630.320.750.010.440.00.710.820.780.740.540.880.55-0.140.490.15
0.120.030.26-0.070.88-0.20.08-0.23-0.180.130.040.090.770.380.42-0.12-0.08-0.4-0.110.30.06-0.03-0.140.2-0.22
0.940.82-0.420.770.510.730.820.740.480.970.220.350.250.09-0.180.880.820.640.880.260.720.650.490.20.14
0.120.010.17-0.07-0.10.15-0.080.00.350.11-0.030.24-0.16-0.01-0.140.270.130.290.140.020.14-0.250.15-0.220.14
Click cells to compare fundamentals

GlaxoSmithKline PLC Account Relationship Matchups

GlaxoSmithKline PLC fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets79.7B80.4B79.1B60.1B59.0B32.8B
Short Long Term Debt Total30.5B27.2B24.2B21.0B18.0B11.0B
Other Current Liab755M765M958M2.3B14.3B15.0B
Total Current Liabilities24.1B22.1B23.7B22.8B21.1B11.2B
Total Stockholder Equity12.0B14.6B15.1B10.6B13.3B14.0B
Property Plant And Equipment Net11.3B11.0B10.7B9.6B10.0B7.2B
Net Debt25.8B20.9B19.9B17.3B15.1B8.3B
Accounts Payable14.9B15.8B17.6B16.3B3.7B6.2B
Cash4.7B6.3B4.3B3.7B2.9B2.7B
Non Current Assets Total60.2B60.2B60.4B39.4B40.4B20.9B
Non Currrent Assets Other1.2B1.1B1.8B5.3B634M1.1B
Cash And Short Term Investments4.8B6.4B4.3B7.9B5.2B4.0B
Common Stock Shares Outstanding2.0B2.0B2.0B2.0B4.1B4.3B
Liabilities And Stockholders Equity79.7B80.4B79.1B60.1B59.0B32.8B
Non Current Liabilities Total37.3B37.5B34.1B27.2B25.1B14.3B
Inventory5.9B6.0B5.8B5.1B5.5B3.0B
Other Stockholder Equity5.2B4.9B4.9B5.1B3.2B2.9B
Total Liab61.3B59.6B57.8B50.1B46.2B25.5B
Property Plant And Equipment Gross10.3B11.0B10.7B9.6B20.2B21.2B
Total Current Assets19.5B20.2B18.7B20.8B18.6B11.9B
Short Term Debt6.9B3.7B3.6B4.0B2.8B2.2B
Common Stock1.3B1.3B1.3B1.3B1.3B1.3B
Retained Earnings5.1B6.8B7.9B4.4B7.2B7.6B
Accumulated Other Comprehensive Income641M1.6B642M(48M)1.6B1.7B
Intangible Assets31.0B29.8B30.1B14.3B14.8B11.4B
Other Liab13.7B14.1B13.5B10.2B11.7B14.2B
Long Term Debt22.6B23.4B20.6B17.0B14.2B17.5B
Good Will10.6B10.6B10.6B7.0B6.8B5.3B
Other Current Assets1.6B617M525M7.7B561M533.0M
Property Plant Equipment11.3B11.0B10.7B9.6B8.7B9.7B
Current Deferred Revenue1.4B1.8B1.6B299M222M233.1M
Other Assets5.1B5.3B6.9B6.9B7.9B5.4B
Net Receivables7.1B7.3B8.0B7.1B7.4B6.5B
Net Tangible Assets(30.1B)(25.8B)(25.6B)(10.8B)(12.4B)(13.0B)
Short Long Term Debt6.7B3.5B3.4B3.8B2.7B4.3B
Long Term Debt Total23.6B23.4B20.6B17.0B19.6B20.5B

GlaxoSmithKline PLC Investors Sentiment

The influence of GlaxoSmithKline PLC's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in GlaxoSmithKline. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to GlaxoSmithKline PLC's public news can be used to forecast risks associated with an investment in GlaxoSmithKline. The trend in average sentiment can be used to explain how an investor holding GlaxoSmithKline can time the market purely based on public headlines and social activities around GlaxoSmithKline PLC ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
GlaxoSmithKline PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for GlaxoSmithKline PLC's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average GlaxoSmithKline PLC's news discussions. The higher the estimated score, the more favorable is the investor's outlook on GlaxoSmithKline PLC.

GlaxoSmithKline PLC Implied Volatility

    
  18.85  
GlaxoSmithKline PLC's implied volatility exposes the market's sentiment of GlaxoSmithKline PLC ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if GlaxoSmithKline PLC's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that GlaxoSmithKline PLC stock will not fluctuate a lot when GlaxoSmithKline PLC's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GlaxoSmithKline PLC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GlaxoSmithKline PLC's short interest history, or implied volatility extrapolated from GlaxoSmithKline PLC options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Managers
Screen money managers from public funds and ETFs managed around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
3.03
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.